BRIEF published on 11/25/2025 at 15:52, 9 months 16 days ago Le groupe Vanguard dévoile sa participation dans American Axle & Manufacturing Actionnariat Groupe Vanguard Formulaire 8.3 Informations Boursières Essieu Américain
BRIEF published on 11/25/2025 at 15:52, 9 months 16 days ago Final Offer Price Notification for ISIN XS2999244754 BNP Paribas Final Offer Price Prospectus Regulation Unsubordinated Notes ISIN XS2999244754
BRIEF published on 11/25/2025 at 15:52, 9 months 16 days ago Avis de prix final pour l'ISIN XS2999244754 BNP Paribas Règlement Sur Les Prospectus Prix De L'offre Finale Notes Non Subordonnées ISIN XS2999244754
BRIEF published on 11/25/2025 at 15:51, 9 months 16 days ago The Vanguard Group Discloses Position in JTC plc Takeover Code Securities Disclosure Vanguard Group Stock Positions JTC Plc
BRIEF published on 11/25/2025 at 15:51, 9 months 16 days ago Le groupe Vanguard révèle sa participation dans JTC plc Groupe Vanguard Code De Prise De Contrôle Information Sur Les Valeurs Mobilières Positions Boursières JTC Plc
BRIEF published on 11/25/2025 at 15:49, 9 months 16 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Disclosure Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 11/25/2025 at 15:49, 9 months 16 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Actionnariat Groupe Vanguard Divulgation Formulaire 8.3 Avadel Pharmaceuticals
BRIEF published on 11/25/2025 at 15:48, 9 months 16 days ago Final Offer Price Notification for ISIN XS2999244838 Final Terms AMF Approval BNP Paribas Issuance ISIN XS2999244838 Subscription Prices
BRIEF published on 11/25/2025 at 15:48, 9 months 16 days ago Avis de prix final pour l'ISIN XS2999244838 Conditions Finales Prix De L'abonnement Approbation AMF Émission De BNP Paribas ISIN XS2999244838
BRIEF published on 11/25/2025 at 15:47, 9 months 16 days ago The Vanguard Group, Inc. Discloses Position in Mural Oncology plc Ordinary Shares Irish Takeover Panel Securities Disclosure Vanguard Mural Oncology
Published on 09/12/2026 at 02:35, 5 hours 6 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 8 hours 41 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 9 hours 36 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 10 hours 16 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 14 hours 41 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 11 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 9 hours 26 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 9 hours 31 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 11 hours 56 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 13 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 12 hours ago Availability of the 2026 Interim Financial Report
